HEMOSONICS AWARDED PRIZE FROM NIH TO EXPAND USE OF QUANTRA HEMOSTASIS SYSTEM TO HELP PREVENT MATERNAL DEATHS
WELL ’ S SUBSIDIARY ‘ WISP ’ LAUNCHES COMPREHENSIVE WEIGHT CARE VERTICAL TO SUPPORT WOMEN STRUGGLING WITH HORMONAL IMBALANCES
NEWS
HEMOSONICS AWARDED PRIZE FROM NIH TO EXPAND USE OF QUANTRA HEMOSTASIS SYSTEM TO HELP PREVENT MATERNAL DEATHS
HemoSonics , LLC , a medical device company focused on acute bleeding management , has announced it has been awarded one of the US $ 525,000 grand prizes in the National Institutes of Health ( NIH ) RADx Tech for Maternal Health Challenge . NIH ’ s RADx Tech for Maternal Health Challenge sought to accelerate the development of innovative diagnostic tools and solutions to address the maternal mortality crisis .
Severe bleeding after childbirth ( postpartum hemorrhage ) is the leading cause of maternal mortality worldwide , according to the World Health Organization . Roughly 14 million women experience PPH annually , and approximately 70,000 die as a result . This problem does not just affect developing nations . The United States reports 21.1 deaths per 100,000 live births , almost twice the Organization for Economic Cooperation and Development average , with more than 10 % of maternal deaths due to bleeding .
HemoSonics was selected for its research and efforts in understanding how its Quantra Hemostasis System may help to improve the management of peripartum bleeding in obstetric patients . Eight winning teams were selected from over 80 initial submissions . Each team successfully progressed through two years of performance assessment that yielded milestone-based interim awards .
“ It is a tremendous validation to receive the RADx award and recognition from NIH to help support research for how the Quantra Hemostasis System may help obstetric patients ,” said HemoSonics ’ President and CEO , Bob Roda . “ Along with the other winners , HemoSonics will work tirelessly to advance technologies that help women have safe and healthy deliveries , wherever they may live , and to improve overall maternal health .”
WELL ’ S SUBSIDIARY ‘ WISP ’ LAUNCHES COMPREHENSIVE WEIGHT CARE VERTICAL TO SUPPORT WOMEN STRUGGLING WITH HORMONAL IMBALANCES
WELL Health Technologies , a digital healthcare company focused on improving health outcomes through technology and empowering healthcare providers globally , is pleased to announce the launch of a new weight care vertical by its majorityowned subsidiary , Wisp , the largest dedicated women ’ s telehealth provider in the US . With Wisp now serving over 1.2 million patients , this expansion represents a pivotal step forward in addressing critical health needs related to hormonal imbalances and weight management for women .
Through this launch , Wisp introduces personalised , online consultations with access to four weight care solutions , including GLP-1 medications , to support women struggling with hormonal conditions such as perimenopause , menopause , Polycystic Ovary Syndrome ( PCOS ) and endometriosis . Additionally , Wisp debuts its first-ever exclusive over-the-counter weight care capsules , designed to promote women ’ s metabolic health .
“ Wisp is committed to providing sustainable support for women ’ s weight loss journeys , addressing a critical yet overlooked aspect of women ’ s health ,” said Monica Cepak , CEO of Wisp . “ As the dialogue around obesity evolves , we recognise that underlying conditions – especially hormonal imbalances linked to perimenopause and menopause – remain under-researched , underdiagnosed and undertreated . With these new offerings , we ’ re proud to continue expanding access to comprehensive care , offering tailored solutions for every woman and every condition at every price point .” �
12 www . intelligenthealth . tech